Systemisk lupus erythematosus
Mer informasjon
Litteratur
-
Systemic Lupus Erythematosus Management in Pregnancy(2022)
Dao KH, Bermas BL
Int J Womens Health. 2022 Feb 15;14:199-211. doi: 10.2147/IJWH.S282604. PMID: 35210867; PMCID: PMC8859727.
-
Svangerskapskomplikasjoner hos kvinner med systemisk lupus erythematosus (2021)
Gøtestam Skorpen, C., Salvesen, K.Å., Palm, Ø., Radtke, M., Wallenius, M.
Tidsskr Nor Laegeforen, 2021.
-
Maternal and fetal complications associated with systemic lupus erythematosus: An updated meta-analysis of the most recent studies (2020)
He WR, Wei H
Medicine (Baltimore). Apr;99(16):e19797
-
Pregnancy outcome in women with active and inactive lupus nephritis: A prospective cohort study(2019)
Attia DH, Mokbel A, Haggag HM, Naeem N
Lupus. 2019 Jun;28(7):806-817. doi: 10.1177/0961203319846650. Epub 2019 May 13. PMID: 31084235
-
Not only disease activity but also chronic hypertension and overweight are determinants of pregnancy outcomes in patients with systemic lupus erythematosus. (2019)
Normand G, Sens F, Puthet J, Jourde-Chiche N, Lemoine S, Chauveau D, Moranne O, Rémy P, Doret M, Daugas E, Juillard L; French Collaborative Group on Lupus Nephritis.
Lupus. 2019 Apr;28(4):529-537. doi: 10.1177/0961203319832097. Epub 2019 Feb 24. PMID: 30799679
-
Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus(2018)
Nahal, S. K., Selmi, C., & Gershwin, M. E.
J Autoimmun, 93, 16-23. doi:10.1016/j.jaut.2018.07.016
-
Influence of disease activity and medications on offspring birth weight, pre-eclampsia and preterm birth in systemic lupus erythematosus: a population-based study(2018)
Skorpen, C. G., Lydersen, S., Gilboe, I. M., Skomsvoll, J. F., Salvesen, K. A., Palm, O., . . . Wallenius, M.
Ann Rheum Dis, 77(2), 264-269. doi:10.1136/annrheumdis-2017-211641
-
Pregnancy in systemic lupus erythematosus and antiphospholipid syndrome(2017)
Fischer-Betz, R., Specker, C.
Best Pract Res Clin Rheumatol, 2017 Jun;31(3):397-414. doi: 10.1016/j.berh.2017.09.011
-
Pregnancy and reproductive aspects of systemic lupus erythematosus.(2017)
Andreoli, L., Crisafulli, F., & Tincani, A.
Curr Opin Rheumatol, 29(5), 473-479. doi:10.1097/bor.0000000000000415
-
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.(2017)
Andreoli, L., Bertsias, G. K., Agmon-Levin, N., Brown, S., Cervera, R., Costedoat-Chalumeau, N., . . . Tincani, A.
Ann Rheum Dis. doi:10.1136/annrheumdis-2016-209770
-
Disease activity during pregnancy and the first year postpartum in women with systemic lupus erythematosus.(2017)
Gøtestam Skorpen, C., Lydersen, S., Gilboe, I. M., Skomsvoll, J. F., Salvesen, K. A., Palm, O., . . . Wallenius, M.
Arthritis Care Res (Hoboken). doi:10.1002/acr.23102
-
Systemic lupus erythematosus and outcomes in first and subsequent births based on data from a national birth registry(2014)
Wallenius, M., Salvesen, K. A., Daltveit, A. K., & Skomsvoll, J. F.
Arthritis Care Res (Hoboken), 66(11), 1718-1724. doi:10.1002/acr.22373
-
Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group.(2003)
Costedoat-Chalumeau, N., Amoura, Z., Duhaut, P., Huong, D. L., Sebbough, D., Wechsler, B., . . . Piette, J. C.
Arthritis Rheum, 48(11), 3207-3211. doi:10.1002/art.11304